During the past decade, Bashkirian Republican Clinical Oncology Dispensary conducted 66 clinical trials. In the 10-year time frame, 66 clinical trials started and 46 clinical trials were completed, i.e. on average, 69.7% percent of trials that started reached the finish line to date. In the past 5 years, 33 clinical trials started and 28 clinical trials were completed. i.e. 84.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bashkirian Republican Clinical Oncology Dispensary" #1 sponsor was "Hoffmann-La Roche" with 37 trials, followed by "Pfizer" with 7 trials sponsored, "Biocad" with 5 trials sponsored, "Amgen" with 4 trials sponsored and "Bayer" with 4 trials sponsored. Other sponsors include 35 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bashkirian Republican Clinical Oncology Dispensary" #1 collaborator was "Merck Sharp & Dohme LLC" with 4 trials as a collaborator, "Genentech, Inc." with 3 trials as a collaborator, "Breast International Group" with 2 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 2 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator. Other collaborators include 25 different institutions and companies that were collaborators in the rest 35 trials.

According to Clinical.Site data, the most researched conditions in "Bashkirian Republican Clinical Oncology Dispensary" are "Breast Cancer" (9 trials), "Non-Small Cell Lung Cancer" (4 trials), "Carcinoma, Non-Small-Cell Lung" (3 trials), "Fallopian Tube Cancer" (3 trials) and "Metastatic Breast Cancer" (3 trials). Many other conditions were trialed in "Bashkirian Republican Clinical Oncology Dispensary" in a lesser frequency.

Most popular intervention types in "Bashkirian Republican Clinical Oncology Dispensary" are "Drug" (91 trials), "Biological" (10 trials), "Other" (6 trials), "Procedure" (4 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (21 trials), "Paclitaxel" (19 trials), "Atezolizumab" (13 trials), "Carboplatin" (11 trials) and "Docetaxel" (10 trials). Other intervention names were less common.

The vast majority of trials in "Bashkirian Republican Clinical Oncology Dispensary" are 80 trials for "All" genders, 14 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Bashkirian Republican Clinical Oncology Dispensary". undefined are not yet recruiting, 15 are recruiting, 27 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 46 completed trials in Bashkirian Republican Clinical Oncology Dispensary, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Bashkirian Republican Clinical Oncology Dispensary, 3 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 66 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".